Center-Authored Papers

Filters: Author is Ramakrishnan, Aravind  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Hayes B, Fagerlie SR, Ramakrishnan A, Baran S, Harkey M, Graf L, Bar M, Bendoraite A, Tewari M, Torok-Storb B.  2008.  Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.. Stem cells (Dayton, Ohio). 26(2):465-73. Abstract
2009
Marcondes AM, Ramakrishnan A, Deeg HJ.  2009.  Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.. Current cancer therapy reviews. 5(4):310-314. Abstract
Ramakrishnan A, Deeg HJ.  2009.  A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease.. Expert opinion on biological therapy. 9(1):21-8. Abstract
2010
Ramakrishnan A, Torok-Storb B.  2010.  The role of the marrow microenvironment in hematopoietic stem cell transplantation.. Cellular therapy and transplantation. 2(7):7-12. Abstract
Ramakrishnan A, Sandmaier BM.  2010.  Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.. Expert review of hematology. 3(1):23-33. Abstract
Scott BL, Ramakrishnan A, Storer BE, Becker PS, Petersdorf SH, Estey EH, Deeg HJ.  2010.  Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.. British journal of haematology. 148(6):944-7. Abstract
Scott BL, Ramakrishnan A, Fosdal M, Storer BE, Becker P, Petersdorf SH, Deeg HJ.  2010.  Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.. British journal of haematology. 149(5):706-10. Abstract
2011
Zhong B, Trobridge GD, Zhang X, Watts KL, Ramakrishnan A, Wohlfahrt M, Adair JE, Kiem H-P.  2011.  Efficient generation of nonhuman primate induced pluripotent stem cells.. Stem cells and development. 20(5):795-807. Abstract
2012
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
2013
Iwata M, Madtes DK, Abrams K, Lamm WJE, Glenny RW, Nash RA, Ramakrishnan A, Torok-Storb B.  2013.  Late infusion of cloned marrow fibroblasts stimulates endogenous recovery from radiation-induced lung injury.. PloS one. 8(3):e57179. Abstract
Ramakrishnan A, Torok-Storb B, Pillai MM.  2013.  Primary marrow-derived stromal cells: isolation and manipulation.. Methods in molecular biology (Clifton, N.J.). 1035:75-101. Abstract
Balakrishnan I, Yang X, Brown J, Ramakrishnan A, Torok-Storb B, Kabos P, Hesselberth JR, Pillai MM.  2013.  Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells.. Stem cells (Dayton, Ohio). Abstract
2014
Gyurkocza B, Gutman J, Nemecek ER, Bar M, Milano F, Ramakrishnan A, Scott B, Fang M, Wood B, Pagel JM et al..  2014.  Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(4):549-55. Abstract
Karoopongse E, Yeung C, Byon J, Ramakrishnan A, Holman ZJ, Jiang PYZ, Yu Q, Deeg HJ, Marcondes AM.  2014.  The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy.. PloS one. 9(9):e107817. Abstract
Kotha S, Murphy ME, Ramakrishnan A, Torok-Storb B, Zheng Y.  2014.  Microvasculature as a gatekeeper for stem cell homing and mobilization. Angiogenesis. 17:302–302. Abstract
Adolescent
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Adult
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Scott BL, Ramakrishnan A, Storer BE, Becker PS, Petersdorf SH, Estey EH, Deeg HJ.  2010.  Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.. British journal of haematology. 148(6):944-7. Abstract
Aged
Scott BL, Ramakrishnan A, Storer BE, Becker PS, Petersdorf SH, Estey EH, Deeg HJ.  2010.  Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.. British journal of haematology. 148(6):944-7. Abstract
Scott BL, Ramakrishnan A, Fosdal M, Storer BE, Becker P, Petersdorf SH, Deeg HJ.  2010.  Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.. British journal of haematology. 149(5):706-10. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract